Silk Road Medical Stock Retained Earnings
SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
Silk |
Silk Road Medical Company Retained Earnings Analysis
Silk Road's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Silk Road Retained Earnings | (399.45 M) |
Most of Silk Road's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
CompetitionBased on the latest financial disclosure, Silk Road Medical has a Retained Earnings of (399.45 Million). This is 142.89% lower than that of the Health Care Equipment & Supplies sector and 153.37% lower than that of the Health Care industry. The retained earnings for all United States stocks is 104.28% higher than that of the company.
Silk Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in retained earnings category among its peers.
Silk Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.14 | |||
Profit Margin | (0.30) % | |||
Operating Margin | (0.34) % | |||
Current Valuation | 1.02 B | |||
Shares Outstanding | 40.63 M | |||
Shares Owned By Insiders | 4.15 % | |||
Shares Owned By Institutions | 97.46 % | |||
Number Of Shares Shorted | 3.15 M | |||
Price To Book | 7.22 X | |||
Price To Sales | 5.83 X | |||
Revenue | 177.13 M | |||
Gross Profit | 100.76 M | |||
EBITDA | (55.48 M) | |||
Net Income | (55.74 M) | |||
Cash And Equivalents | 108.87 M | |||
Cash Per Share | 3.09 X | |||
Total Debt | 84.63 M | |||
Debt To Equity | 1.37 % | |||
Current Ratio | 6.92 X | |||
Book Value Per Share | 3.81 X | |||
Cash Flow From Operations | (32.01 M) | |||
Short Ratio | 2.48 X | |||
Earnings Per Share | (1.45) X | |||
Price To Earnings To Growth | (0.26) X | |||
Target Price | 20.75 | |||
Number Of Employees | 474 | |||
Beta | 1.54 | |||
Market Capitalization | 1.12 B | |||
Total Asset | 265.31 M | |||
Retained Earnings | (399.45 M) | |||
Working Capital | 210.55 M | |||
Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |